Metolazone

Routes
Oral (PO)
Half-Life (t½)
PO: 14h
Formula
C16H16ClN3O3S
Molecular Weight
365.83 g/mol
PubChem CID
4170
Aliases
Zaroxolyn

Pharmacological Mechanism

Thiazide-like diuretic — same NCC blockade as HCTZ but works synergistically with loop diuretics in diuretic-resistant heart failure. Powerful natriuresis when sequentially blocking distal tubule downstream of loop-treated proximal segments.

Half-Life & Elimination Curve (PO: 14h)

100%50%25%12.5%0%0h0×t½14h1×t½28h2×t½42h3×t½56h4×t½70h5×t½0×t½ (0h): 100% remaining (~22.3 µg/L)1×t½ (14h): 50% remaining (~11.2 µg/L)2×t½ (28h): 25% remaining (~5.58 µg/L)3×t½ (42h): 12.5% remaining (~2.79 µg/L)4×t½ (56h): 6.3% remaining (~1.39 µg/L)5×t½ (70h): 3.1% remaining (~0.697 µg/L)
Plasma (PO)t½ Decay (14h)
  • 0×t½0h100% (22.3 µg/L)
  • 1×t½14h50% (11.2 µg/L)
  • 2×t½28h25% (5.58 µg/L)
  • 3×t½42h12.5% (2.79 µg/L)
  • 4×t½56h6.3% (1.39 µg/L)
  • 5×t½70h3.1% (0.697 µg/L)
Elimination t½14h (PO)
Rate Constant (ke)0.0495 h⁻¹
Time to Peak (Tmax)5.13h
Est. Peak (Cmax)22.3 µg/L
Clearance (CL)5.59 L/h
97% Washout (5×t½)70h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References